Please assess the completion status of the following clinical trial:

Trial Title: Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic heart failure patients in dilated stages~* Etiologies: dilated cardiomyopathy, chronic hypertensive cardiopathy in dilated stage, chronic coronary cardiopathy in dilated stage~* Ejection fraction ≤ 40%.~* Patients who are stable under optimal medical treatment for a period of at least 3 months prior to randomization~Exclusion Criteria:~* Severe or persistent heart failure~* Recurrent myocardial ischemia~* Uncontrolled ventricular tachycardia~* Malignant disease (life expectancy of less than one year)~* Manifest ventricular asynchrony~* Hematologic disease~* Recent cerebrovascular disease~* Recent acute coronary syndrome~* Serum creatinine \>2.26 mg/dL (200 umol/L)~* Atrial fibrillation without heart rate control in the last 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- ucMSC (Type: EXPERIMENTAL): Umbilical cord derived mesenchymal are injected intravenously to Patients.
- Controls (Type: PLACEBO_COMPARATOR): Intravenous placebo solution are administrated to Patients.

Based on this trial design, predict the completion outcome and termination type (if applicable).